Even as Maryland’s medical marijuana industry continues to move through bureaucracy, a firm looking to provide testing and analytics is getting set up.
Steep Hill Maryland said it received pre-approval from the Maryland Medical Cannabis Commission to test medical cannabis. It’s the first testing company to get the go-ahead. The company, which has a license to operate from Berkeley, Calif.-based Steep Hill, is looking to set up a lab in Columbia.
As we reported when Steep Hill first announced a Maryland presence, the company tests medical cannabis for potency and safety. It’s led by Andrew Rosenstein, who is gastroenterology director at the University of Maryland Saint Joseph Medical Center and a professor at the University of Maryland School of Medicine in Baltimore.
The state picked dispensaries and growers. Testing is another part of the equation to make sure patients are getting good product.
There’s also a bill in the General Assembly this session to legalize recreational marijuana, which Steep Hill’s California operation also tests.
Join our growing Slack community
Join 5,000 tech professionals and entrepreneurs in our community Slack today!
Donate to the Journalism Fund
Your support powers our independent journalism. Unlike most business-media outlets, we don’t have a paywall. Instead, we count on your personal and organizational contributions.
From Belgaum to Baltimore and beyond, this founder leaned on family to build a biotech juggernaut
Tech-related orders and economic reorganizations hit Maryland. Here’s what they mean.
Philly vs. Kansas City: Who’s got the stronger tech economy?
